Results 171 to 180 of about 12,697,710 (368)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Pathogenic variants in KIF1C cause Spastic Paraplegia 58 (SPG58), typically presenting with cerebellar ataxia and spastic paraparesis. We report two unrelated patients with spastic paraparesis, cerebellar ataxia, and tremor. Whole‐exome sequence analysis identified novel homozygous variants in the motor domain of KIF1C (NM_006612.6): c.921G>A (
Akihiko Mitsutake +12 more
wiley +1 more source
Empowering women in health technology
The Lancet: Digital Health, 2022 The Lancet Digital Health
doaj +1 more source
Digital health for aging populations
Nature Medicine, 2023 Chuanrui Chen, Shichao Ding, Joseph Wang
semanticscholar +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Guiding better design and reporting of AI-intervention trials
The Lancet: Digital Health, 2020 The Lancet Digital Health
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Thank you to The Lancet Digital Health's clinical and statistical peer reviewers in 2021
The Lancet: Digital Health, 2022 The Lancet Digital Health Editors
doaj +1 more source
Frontiers in PsychiatryBackgroundMental health concerns among children and young people are rising, yet only a fraction receive the care they need. Digital mental health solutions can help bridge this gap, and recent years have seen a rapid proliferation of mental health ...
Emily P. Cowling +12 more
doaj +1 more source
The growing need to integrate digital mental health into psychiatric and medical education [PDF]
Jorge López‐Castromán +6 more
openalex +1 more source